CTI established a biotechnology company, including animal diagnosis and treatment services
According to the Qichacha APP, recently, Guangxi Hechi Pinsheng Biotechnology Co., Ltd. was established with a registered capital of 10 million yuan. Its business scope includes: animal diagnosis and treatment; artificial breeding of nationally key protected terrestrial wild animals; artificial breeding of provincially key protected terrestrial wild animals; production of laboratory animals, etc. Qichacha's equity penetration shows that the company is wholly owned by CTI
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments